The Journal of Urology
Volume 181, Issue 3 , Pages 1361-1371 , March 2009

Response of Bladder Carcinoma Cells to TRAIL and Antisense Oligonucleotide, Bcl-2 or Clusterin Treatments

  • Bo Sun

      Affiliations

    • Department of Surgery, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Jacob A. Moibi

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Allan Mak

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Zhengwen Xiao

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Wilson Roa

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Ronald B. Moore

      Affiliations

    • Department of Surgery, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationCorrespondence: Department of Surgery, University of Alberta, 2D2.16 Walter Mackenzie Health Sciences Centre, 8440 112 St., Edmonton, Alberta, Canada T6G 2B7 (telephone: 780-407-6330; FAX: 780-407-6331)
    • Financial interest and/or other relationship with Quest Pharmatech and Nat Immune.

Received 18 July 2008

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Canadian Cancer Society through National Cancer Institute of Canada Grant 15105.

PII: S0022-5347(08)02996-0

doi: 10.1016/j.juro.2008.10.148

The Journal of Urology
Volume 181, Issue 3 , Pages 1361-1371 , March 2009

Article Tools

* Image Usage & Resolution